特朗普的行政命令旨在将毒品价格大幅降低80%,对印度公司的影响有限。 Trump's executive order aims to slash drug prices by up to 80%, with limited impact on Indian firms.

美国总统特朗普降低毒品价格的行政命令旨在使用最惠国定价模式,将成本降低80%。 US President Trump's executive order to reduce drug prices aims to lower costs by up to 80% using a Most Favoured Nation (MFN) pricing model. 不过,预计这将对印度制药公司影响最小,因为它们主要出口低价非专利药品,利润微薄。 However, this is expected to have a minimal impact on Indian pharmaceutical companies, as they mainly export low-priced generic drugs with slim profit margins. 虽然订单针对的是高利润品牌药品,但随着全球公司寻求削减成本,合同制造机会可能会出现。 While the order targets high-margin branded drugs, contract manufacturing opportunities may arise as global companies seek to cut costs.